We found a higher percentage of cells expressing the inhibitory molecule NKG2A among the NKp46+CD3− population derived from OMCR16-001 CRC, compared to the same population sorted from OMCR16-030 and OMCR16-082 CRC (Figure 6D). This evidence concerns the gene KLRC1 and colorectal carcinoma.